Cleared Traditional

Endoform Dental Membrane (K231305) - FDA 510(k) Clearance

Class II Dental device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K231305 · Aroa Biosurgery , Ltd. · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2024
Decision
263d
Days
Class 2
Risk

K231305 is an FDA 510(k) clearance for the Endoform Dental Membrane. Classified as Barrier, Animal Source, Intraoral (product code NPL), Class II - Special Controls.

Submitted by Aroa Biosurgery , Ltd. (Auckland, NZ). The FDA issued a Cleared decision on January 23, 2024 after a review of 263 days - an extended review cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3930 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Aroa Biosurgery , Ltd. devices

Submission Details

510(k) Number K231305 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 05, 2023
Decision Date January 23, 2024
Days to Decision 263 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
136d slower than avg
Panel avg: 127d · This submission: 263d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NPL Barrier, Animal Source, Intraoral
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3930
Definition An Animal Source Dental Barrier Is An Animal-derived Material Device, Such As Collagen, Intended To Aid In Guided Tissue/bone Regeneration Procedures And To Act As A Stable Barrier For The Containment Of Bone Graft Materials When Placed Around Implants.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - NPL Barrier, Animal Source, Intraoral

All 18
Devices cleared under the same product code (NPL) and FDA review panel - the closest regulatory comparables to K231305.
SwissMembrane X
K250833 · Geistlich Pharma AG · Apr 2025
Soft Tissue Augmentation Resorbable Matrix
K233203 · Collagen Matrix, Inc. · May 2024
Oral Matrix
K231513 · Beijing Biosis Healing Biolog Ical Technology Co., Ltd. · Feb 2024
THE Cover
K230091 · Purgo Biologics, Inc. · Oct 2023
InterCollagen® Guide
K223912 · Sigmagraft, Inc. · Aug 2023
Kerecis Oral
K213904 · Kerecis · Sep 2022